Gastrointestinal and Liver Disorders Are Increasing: Dr. Chalapathi Rao Achanta

IMT News Desk
IMT News Desk
· 2 min read
Dr. Chalapathi Rao Achanta highlights rising GI and liver disorders due to lifestyle changes at the Gastro Update Conference at KIMS Hospitals

Gastrointestinal and liver diseases are increasing as part of changing lifestyles, said Dr. Chalapathi Rao Achanta, Senior Consultant Gastroenterologist and Chairman of the Organizing Committee of the Gastro Update Conference, organized jointly by the Institute of Liver and Gastro Sciences at KIMS Hospitals, Seethammadhara, the Association of Physicians of India (API), the Indian Medical Association (IMA), and the Vizag Gut Club.

Speaking on the occasion, Dr. Chalapathi Rao stated that gastrointestinal and liver-related disorders are on the rise in the country. Academic discussions on complex cases not only enhance the diagnostic capabilities of doctors but also play a key role in providing better treatment to patients. He further noted that such conferences are highly important for young doctors. Through the discussion of complex cases, young doctors can learn valuable clinical insights. They also get exposure to emerging technologies and treatment modalities in the field.

The conference witnessed participation from eminent medical experts from New Delhi, Mumbai, Hyderabad, Bhubaneswar, and Ahmedabad. Experts deliberated on several challenging topics, including dysphagia (difficulty in swallowing), treatment-resistant indigestion, recurrent jaundice, chronic diarrhea, liver cancers, complex gastroesophageal reflux disease, recurrent perianal fistula, severe pancreatitis, and recurrent gastrointestinal bleeding.

Interactive case-based sessions centered on real patient cases emerged as a major highlight of the conference. National and regional experts jointly analyzed the cases and provided valuable insights into modern diagnostic approaches and treatment strategies.

Dr. Abhinay, CEO of KIMS Group of Hospitals, and Dr. Nagesh, Regional CEO, expressed their gratitude to the faculty members, delegates, and partner organizations for their contribution to the success of the conference. They stated that the overwhelming response received for the conference once again demonstrated that Visakhapatnam is emerging as a key center for medical education, research, and advanced training in the fields of gastroenterology and hepatology.

Read Next

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director
News
July 14, 2026

PM Modi to Dedicate Key Healthcare Infrastructure Projects to Nation on July 17: PGIMER Director

Prime Minister Narendra Modi will dedicate several key healthcare infrastructure projects to the nation on July 17, according to PGIMER Director Dr Vivek Lal. The projects include the Advanced Mother and Child Centre, the Advanced Neurosciences Centre and a new Critical Care Block, all of which are expected to strengthen tertiary care services and expand […]
Article by: IMT News Desk
OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars
News
July 14, 2026

OneSource Specialty Pharma and Formycon AG Announce Strategic Manufacturing Partnership for Biosimilars

OneSource Specialty Pharma Limited and Formycon AG have announced a strategic manufacturing partnership for biosimilars, bringing together Formycon’s biosimilar development expertise and OneSource’s integrated biologics manufacturing capabilities to support global markets. Under the agreement, OneSource will serve as a strategic manufacturing partner for Formycon and provide both drug substance and drug product manufacturing from its […]
Article by: IMT News Desk
FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi
News
July 14, 2026

FDA Approves At-Home Starter Dose of Eisai-Biogen’s Alzheimer’s Drug Leqembi

The U.S. Food and Drug Administration has approved an at-home starting dose of Eisai and Biogen’s Alzheimer’s drug Leqembi, allowing some patients to begin treatment with injections administered by themselves or a caregiver. The decision expands access to the drug’s subcutaneous formulation, which can now be used as a starter dose rather than only after […]
Article by: IMT News Desk
Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition
News
July 14, 2026

Emcure Pharmaceuticals Consolidates Full Ownership of Gennova Amid Leadership Transition

Emcure Pharmaceuticals Limited has announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus on biologics and biosimilars. The company is acquiring the entire 12.05% minority stake in Gennova held by Dr Sanjay Singh and others, taking its ownership to 100% and making Gennova […]
Article by: IMT News Desk